Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tatsuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
Author Information
  1. Shin Fukudo: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan. sfukudo@med.tohoku.ac.jp. ORCID
  2. Toshikatsu Okumura: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  3. Masahiko Inamori: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  4. Yusuke Okuyama: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  5. Motoyori Kanazawa: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  6. Takeshi Kamiya: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  7. Ken Sato: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  8. Akiko Shiotani: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  9. Yuji Naito: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  10. Yoshiko Fujikawa: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  11. Ryota Hokari: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  12. Tatsuhiro Masaoka: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  13. Kazuma Fujimoto: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  14. Hiroshi Kaneko: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  15. Akira Torii: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  16. Kei Matsueda: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  17. Hiroto Miwa: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  18. Nobuyuki Enomoto: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  19. Tooru Shimosegawa: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
  20. Kazuhiko Koike: Guidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.

Abstract

No abstract text available.

Word Cloud

Created with Highcharts 10.0.0Correction:Evidence-basedclinicalpracticeguidelinesirritablebowelsyndrome2020

Similar Articles

Cited By